We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

August 16, 2019

Social Innovation for Health

Commentary
Jeff Gombala
Tessy Huss

At HealthXL, we are all about shared knowledge and collaboration. We worked together with one of our members, ZS Associates, to put together this blog. Special thanks to Jeff Gombala for co-authoring and Naveen Rao of Patchwise Labs for the postface. 

According to the Healthy People 2020 initiative, ‘Social determinants of health are conditions in the environments in which people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.’ 

Political and economic forces determine people’s daily circumstances, such as access to public goods such as health care, education, transportation, work and housing. Research has estimated that a small, albeit significant, fraction of population health is shaped by medical care. Studies suggest that 80 to 90% of health outcomes are attributable to non-medical social determinants of health (SDoH). For instance, smoking, physical activity, sleep patterns, financial security, loneliness, access to transportation, culture and tradition and more have a tremendous impact on health outcomes in people’s day to day lives.


A screenshot of a cell phoneDescription automatically generated
  Source ZS Associates


The promise of digital health and SDoH innovation

The true promise of digital health technologies is the ability to enhance our capacity to effectively prevent, diagnose, treat, and manage disease via digital technologies. The table below provides some examples of digital health interventions and their application.



There is no shortage of innovations and announcements in recent news (IPOs, funding announcements) supporting the excitement of the digital health promise. For example, in recent weeks:


Social determinants matter but who’s acting?

Physicians agree on the impact SDoH have on an individual’s health, yet many believe the responsibility lies elsewhere. The Government has meaningfully stepped up to support new market opportunities for addressing SDoH: Medicaid’s managed care markets have allotted dedicated reimbursements in North Carolina, Massachusetts, New York, California, Oregon, and a growing list of other states, while CMS expansion of supplemental benefits to address non-clinical factors will reshape the opportunity for America’s 22m seniors in Medicare Advantage plans starting in 2020.

With these new incentives in place, there is a growing opportunity for both the health insurance and pharmaceutical industries to explore strategic investments and partnerships that can improve clinical and financial outcomes:

Postface by Naveen Rao, Patchwise Labs 

As digital health innovation reaches this new frontier, the biggest breakthroughs will require a transdisciplinary approach. Successful SDoH innovations will require equal parts technology and data, social science, and behavioral science if they are to create effortless, accessible, and consumer friendly technology-driven experiences.

Perhaps more than anything, meaningful social determinants strategy requires a new outlook that will no doubt prove challenging to traditional industry motivations of years past. Making long-term investments in people’s well-being will not always yield demonstrable returns to a lab value or performance metric due to the challenges of insurance churn, data collection and measurement, and the age-old issue of behavior change.

But at this early stage of adoption, those organizations willing to demonstrate creativity and proactive approaches could see the greatest reward as the market heats up for new ideas. As we prepare to enter the third decade of the 21st Century, technology will play an increasing role. Yet any solution to help people improve their health outside the doctor’s office will have to incorporate the vital aspects of humanity that have gone missing: empathy and listening in the form of needs assessments and screenings, provision of easy to access social support and responsive communication. 

For Healthcare, the emerging SDoH  frontier may prove to be just as much about ‘care’ as about ‘health'.

Dr. Brennan Spiegel, a physician-scientist at Cedars-Sinai Medical Center sums this up quite nicely

“Digital Health… is a social science and behavioral science. Creating the tech isn’t the hard part. The hard part is using the tech to change patient behavior. And that is really hard to do.”

Digital health offers many promising solutions to address the SDoH as it enables a better understanding of the mechanisms underpinning health inequities. As digital health solutions expand across all tenets of public and private life, how, if at all, will this impact, health outcomes of populations?
Reach out to us and let us know what you think! We'd love to continue these discussions at our Global Gathering in Lake Nona on November 20th. Click here to join us!



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Pharmacies in the US as a Distribution Model for DTx

30th March @ 10:45 AM EDT

The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.

Featuring
Mark Thomas
Mark Thomas
Healthcare Consultant, ProspHire
Featuring
Mark Thomas
Mark Thomas
Healthcare Consultant, ProspHire
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Understanding the Burden of Digital Health Compliance: Regulations, Security & Privacy

13th April 2023 @ 10:45AM EDT

Are your Digital Health innovations being slowed or even derailed by regulatory, security, privacy or legal compliance considerations? Apply now to join HealthXL in this expert led Masterclass to deep dive into this topic.

Featuring
Randy Horton
Randy Horton
VP of Solutions and Partnerships, Orthogonal
Featuring
Randy Horton
Randy Horton
VP of Solutions and Partnerships, Orthogonal
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: How Can DTx Companies Enter the US Market Successfully?

27th April 2023 @ 10:45 AM EDT

Despite the rapid expansion of the digital therapeutics (DTx) market in the US, DTx companies are still facing challenges in establishing a foothold and making an impact in the digital health industry. Join this masterclass with Jonas Duss (Co-Founder at Kaia Health) to discuss the key challenges facing DTx companies seeking to enter the US market. Seats are limited so apply now to secure your place.

Featuring
Jonas Duss
Jonas Duss
Co-Founder, Kaia Health
Featuring
Jonas Duss
Jonas Duss
Co-Founder, Kaia Health
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: When and how should your digital health solution be regulated?

11th May @ 10:45AM EDT

Do you need guidance on the best practices for gaining regulatory approval for your digital health solution? Then this masterclass is the perfect fit for you! Apply now to secure your place.

Featuring
Acacia Parks
Acacia Parks
Lead Consultant and Founder, Liquid Amber Consulting
Featuring
Acacia Parks
Acacia Parks
Lead Consultant and Founder, Liquid Amber Consulting

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
28th March 2023 @ 10:45AM EDT

Masterclass: Current State of Routes to Market in Digital Health

Digital health solutions can be commercialized in various ways depending on factors such as value proposition, stakeholders, and regulatory requirements. Join this expert led Masterclass to dive deeper into this topic.

Maurice Solomon
Featuring
Maurice Solomon
Principal, ZS
Clinical Trials Innovation
29th March 2023 @ 10:45AM EDT

Masterclass: Design and Control Conditions for Clinical Trials of Digital Health Solutions

Clinical efficacy is a crucial factor for the commercial success of Digital Health solutions. Apply now to join HealthXL in this session as we deep dive into this topic.

David Hohenschurz-Schmidt
Featuring
David Hohenschurz-Schmidt
Postgraduate Researcher, Imperial College London
Digital Therapeutics (DTx)
30th March @ 10:45 AM EDT

Pharmacies in the US as a Distribution Model for DTx

The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.

Mark Thomas
Featuring
Mark Thomas
Healthcare Consultant, ProspHire
Clinical Trials Innovation
4th April 2023 @ 10:45 AM EDT

Masterclass: Operations Considerations for Designing Clinical Trials for Digital Health Solutions

Conducting RCTs is a significant undertaking that requires substantial investments and financial resources. Apply now to join your peers in this expert led Masterclass.

Jessica Lake, PhD
Featuring
Jessica Lake, PhD
Chief Science Officer, Limbix

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.